北美感染控制市场 – 行业趋势和 2030 年预测

北美感染控制市场分析及规模

根据 NCBI 发表的研究，根据国家医院感染监测 (NNIS) 系统报告的统计数据，大多数医院内感染与导管插入有关，而 CA-菌尿是全球最常见的 HAI，每年占美国 HAI 的 40%。市场主要受需要高强度感染预防的外科手术增加的推动。这种高偏好是由于感染控制使用相关的积极临床结果。感染可能通过用于治疗患者的受污染或未消毒的手术或医疗设备或医疗机构中受污染的环境直接或间接地从一个人传播到另一个人。

Data Bridge Market Research 分析，感染控制市场在 2022 年的规模为 139.8957 亿美元，预计到 2030 年将达到 387.9994 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 13.6%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

北美感染控制市场范围和细分  

Market Definition

The process of infection control is used in the healthcare sector to stop or prevent the spread of infections. The activity of infection control involves getting rid of bacteria from various surfaces and things. This procedure makes it possible for people to avoid disease transmission . A scientific strategy called infection control is intended to stop the harm infections can do to patients and healthcare professionals. In all healthcare settings, infection control is necessary to stop the spread of infectious diseases. It can be described as a set of generally accepted suggestions used to decrease the danger of infectious agents being transmitted by environmental or bodily fluids.

North America Infection Control Market Dynamics

Drivers

• Increasing need to prevent hospital-acquired infections

The sterilization products and services industry under the product and services area is predicted to have profitable expansion because of the growing need to prevent hospital-acquired infections and the extensive usage of sterilization equipment in healthcare settings. The World Health Organization (WHO) reports that at least 30 new diseases have appeared in the previous 20 years and that infectious diseases claim the lives of 17 million people each year. Additionally, it is predicted that the market would rise throughout the forecast period due to an increase in surgeries, an increase in the incidence of infectious diseases and growth in the healthcare sector.

• Awareness about the infection control

The CDC estimates that up to 1.7 million hospitalized patients in the US regularly get clinical care linked to pollution (HCAIs) while receiving treatment for other medical conditions and that more than 98,000 of these patients (or one out of every 17) pass away as a result of HCAIs. Urinary tract infections account for 32% of all HAIs in the nation; cautious site infections account for 22%; lung (pneumonia) diseases account for 15%; and circulatory system illnesses account for 14%. This ought to maintain consumer interest in sanitizer and disinfectant products. The likelihood of HAIs depends heavily on the patient's safety, infection control procedures and the frequency of various compelling experts in the clinical benefits office. Longer clinical centre stays result from several factors, including immunosuppression, increased age and stays in specialized care units. Around 20% of such illnesses occur in ICUs. The critical microorganisms causing HAIs to integrate C. difficile, Staphylococcus aureus, Klebsiella and Escherichia coli.

Opportunities

• Rising adoption of single-use medical nonwovens and devices

The number of surgical procedures performed each year has increased significantly due to an ageing population and an increase in the prevalence of obesity and diabetes. As a result, there is a greater demand for disposable medical products or single-use products that can be discarded after use, reducing the risk of infection transmission. The increasing importance of maintaining hygiene and sterility as well as rising per capita healthcare spending, are expected to drive demand for single-use medical nonwoven products. The emergence of pandemics such as H1N1, SARS and COVID-19 as well as viral diseases such as Zika virus, yellow fever, Ebola, and dengue fever, has increased demand for single-use medical nonwoven products.

Restraints/Challenges

• Presence of harmful and toxic chemical-based sanitizers available in the local markets

The bulk of synthetic sanitizers that are now on the market has negative characteristics. For instance, sodium hypochlorite is an effective therapy for blood-borne pathogens, but it is also highly destructive, aggravates respiratory conditions in building occupants, and is deadly when released into the environment. The improper use of these sanitizers can endanger the environment and be harmful to any patients that may be exposed to them.

This infection control market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infection control market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2020, Ecolab received EPA approval for its AdvaCare Disinfectant laundry disinfectant and oxidizer, emerging viral pathogen claim against SARS-CoV-21, the virus that causes COVID-19. This EPA approval expanded the company's market in the future.
• In 2019, Ecolab received U.S. EPA approval for its OxyCide daily disinfectant cleaner for efficacy against Candida auris (C. auris), a fungal pathogen that causes major health issues worldwide. The company's EPA approval increased market demand for its product, resulting in increased sales in the future.

North America Infection Control Market Scope

The infection control market is segmented on the basis of product, application, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Sterilization
• Cleaning and Disinfection
• Personal Protective Barriers
• Endoscope Reprocessing
• Anti-Microbial Surfaces
• Other Infection Control

 Application

• Surgical Instruments
• Surgical Endoscopes
• Ultrasound Probes
• Others

 Distribution Channel

• Direct Tender
• Retail Sales
• Third Party Distributors

End User

• Hospitals
• Clinics
• Medical Device Companies
• Pharmaceutical and Biotechnology Companies
• Laboratories
• Others

Infection Control Market Regional Analysis/Insights

The infection control market is analyzed and market size insights and trends are provided by country, product, application, distribution channel and end user as referenced above.

The countries covered in the infection control market report are U.S., Canada and Mexico in North America.

U.S. is dominating the infection control market as the top market players expand their product offerings and virus transmission capabilities, the partnerships that occupy the most populous region in the United States will be strengthened.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

感染控制市场还为您提供每个国家/地区资本设备医疗支出增长、感染控制市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对感染控制市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和感染控制市场份额分析

感染控制市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对感染控制市场的关注有关。

感染控制市场的一些主要参与者包括：

• STERIS plc（美国）
• Sotera Health Company（美国）
• Getinge AB（瑞典）
• 先进灭菌产品 (ASP)（美国）
• Ecolab Inc.（美国）
• 3M（美国）
• MATACHANA集团（西班牙）
• MMM集团（德国）
• Belimed AG（瑞士）
• 利洁时（英国）
• Metrex Research LLC（英国）
• Miele集团（德国）
• Pal International（英国）
• MELAG Medizintechnik GmbH & Co. KG（德国）
• Contec, Inc.（美国）
• 梅达尔坎（希腊）
• Systec GmbH (德国)
• CBMSrl 医疗设备（意大利）
• 大陆设备公司（美国）
• BGS Beta-Gamma-Service GmbH & Co. KG（德国）

SKU-55598